𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression

✍ Scribed by Kay-Uwe Wagner; Hallgeir Rui


Publisher
Springer US
Year
2008
Tongue
English
Weight
237 KB
Volume
13
Category
Article
ISSN
1083-3021

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Protein kinase C in Wnt signaling: Impli
✍ Luis Bernardo Luna-Ulloa; José G. Hernández-Maqueda; M. Cristina Castañeda-Patlá 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

## Abstract Although it is well known that Wnt and protein kinase C (PKC) signaling pathways are both involved in carcinogenesis and tumor progression, their synergistic contribution to these processes or the crosstalk between them has just recently been approached. The Wnt and PKC signaling are in

P110 Defect of JAK2/STAT5 signalling pat
✍ E. Gulya; P. Gombás; A. Kárpáti; K. Kristó; A. Matolcsy; Z. Mátrai; K. Pecze 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

bicytopenia (anemia and thrombocytopenia). She is again transfusion dependent and on H1 and H2 blockers. Conclusion: Cladribine therapy is efficient in patient with systemic mastocytosis but response is transient so there is need for new therapy options in this rare hematologic disease. P110 Defect

New signaling pathways from cancer progr
✍ Gregory S. DeLassus; Hyojin Cho; George L. Eliceiri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

We observed previously that each of seven cancer progression inhibitors suppresses the mRNA expression of some matrix metalloproteinases (MMPs), but stimulates that of others, in breast cancer cells. In the present study we tested the effect of overexpressing other cancer modulators on MMP expressio

Trichostatin A, a histone deacetylase in
✍ Hua Xiong; Wan Du; Yan-Jie Zhang; Jie Hong; Wen-Yu Su; Jie-Ting Tang; Ying-Chao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

## Abstract Aberrant janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is involved in the oncogenesis of several cancers. Suppressors of cytokine signaling (SOCS) genes and SH2‐containing protein tyrosine phosphatase 1 (SHP1) proteins, which are negative regulator